Insperity Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw Adjusted EPS down 17% and Adjusted EBITDA up 1% year-over-year, with margin recovery offsetting lower worksite employee volume. Full-year guidance was reiterated for Adjusted EBITDA, while worksite employee growth was revised downward due to macroeconomic headwinds and strategic pricing impacts.
Fiscal Year 2025
-
Q4 2025 results reflected ongoing macro and healthcare cost headwinds, with adjusted EPS at -$0.60 and adjusted EBITDA at -$13M. 2026 guidance anticipates margin recovery, lower operating expenses, and the HRScale rollout, with adjusted EBITDA forecasted to rise 30%-76%.
-
Q3 2025 results were impacted by a sharp rise in healthcare claims, leading to lower-than-expected earnings despite strong client retention and sales momentum. Strategic pricing, a new UHC contract, and the HRScale rollout are expected to drive a rebound in 2026.
-
Q2 2025 results were slightly below guidance due to higher benefits costs, but worksite employee growth and sales efficiency improved. Management raised full-year benefits cost guidance and remains focused on pricing, plan design, and expense management to drive profitability in 2026, with the Workday partnership and new HR solutions expected to support future growth.
-
Q1 results missed guidance due to higher benefits costs and delayed client starts amid economic uncertainty. Client retention and sales activity were strong, but 2025 growth guidance was trimmed. The Workday partnership achieved key milestones, with a new joint solution expected to drive future growth.
Fiscal Year 2024
-
Q4 2024 results exceeded guidance on Adjusted EPS and EBITDA, driven by strong sales and retention despite weak client hiring. The Workday partnership advanced with key milestones set for 2025, and guidance anticipates modest worksite employee growth and continued investment.
-
Q3 2024 saw solid Adjusted EPS and EBITDA despite a 2% decline in paid worksite employees, with strong client retention and disciplined pricing offsetting weak hiring. Full-year guidance was narrowed to the lower end, and significant investments continue in AI and the Workday partnership.
-
Adjusted EPS and EBITDA grew strongly year-over-year, driven by lower benefit costs and strong pricing, despite a decline in paid worksite employees due to economic headwinds. Guidance for 2024 EPS and EBITDA was raised, with continued investment in the Workday partnership and strong client retention at 99%.